We thank M.L. Duiverman, F.M. Struik and P.J. Wijkstra for the relevant comments and agree that development of new therapeutic options in severe-stable chronic obstructive pulmonary disease is required.
We concur that the …
We thank M.L. Duiverman, F.M. Struik and P.J. Wijkstra for the relevant comments and agree that development of new therapeutic options in severe-stable chronic obstructive pulmonary disease is required.
We concur that the …